Martin Marino - Microbix Biosystems Independent Chairman of the Board

MBX Stock  CAD 0.30  0.01  3.23%   

Chairman

Mr. Martin A. Marino is Independent Director of the Company since 2020.
Tenure 4 years
Address 265 Watline Avenue, Mississauga, ON, Canada, L4Z 1P3
Phone905 361 8910
Webhttps://www.microbix.com
Marino is a Pharmaceutical Executive, Ontario, Canada. Previously he was Global General Counsel, Merck Generics Group, Germany. His background is legal and financial. He has a law degree and was general counsel to companies in the pharmaceutical industry.

Microbix Biosystems Management Efficiency

The company has return on total asset (ROA) of 0.0382 % which means that it generated a profit of $0.0382 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2004 %, meaning that it generated $0.2004 on every $100 dollars invested by stockholders. Microbix Biosystems' management efficiency ratios could be used to measure how well Microbix Biosystems manages its routine affairs as well as how well it operates its assets and liabilities. As of the 24th of November 2024, Return On Tangible Assets is likely to drop to -0.0012. In addition to that, Return On Capital Employed is likely to drop to -0.08. At this time, Microbix Biosystems' Asset Turnover is very stable compared to the past year.
Microbix Biosystems has accumulated 6.65 M in total debt with debt to equity ratio (D/E) of 0.53, which is about average as compared to similar companies. Microbix Biosystems has a current ratio of 1.61, which is within standard range for the sector. Debt can assist Microbix Biosystems until it has trouble settling it off, either with new capital or with free cash flow. So, Microbix Biosystems' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Microbix Biosystems sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Microbix to invest in growth at high rates of return. When we think about Microbix Biosystems' use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 1 records

CHAIRMAN Age

William RiceAptose Biosciences
65
Microbix Biosystems Inc., a life science company, manufactures viral and bacterial antigens and reagents for the diagnostics industry worldwide. Microbix Biosystems Inc. was founded in 1988 and is based in Mississauga, Canada. MICROBIX J is traded on Toronto Stock Exchange in Canada. Microbix Biosystems (MBX) is traded on Toronto Exchange in Canada and employs 14 people. Microbix Biosystems is listed under Biotechnology category by Fama And French industry classification.

Management Performance

Microbix Biosystems Leadership Team

Elected by the shareholders, the Microbix Biosystems' board of directors comprises two types of representatives: Microbix Biosystems inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Microbix. The board's role is to monitor Microbix Biosystems' management team and ensure that shareholders' interests are well served. Microbix Biosystems' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Microbix Biosystems' outside directors are responsible for providing unbiased perspectives on the board's policies.
Mark Cochran, Independent Director
Philip Casselli, Senior Vice President - Business Development and Sales, Marketing
Kevin Cassidy, Senior Vice President Sales and Business Development
William Gastle, Founder, Executive Chairman, Member of Audit Committee and Member of HR, Compensation and Governance Committee
Mark Luscher, Senior Vice President - Scientific Affairs
Christopher Lobb, General Officer
Joseph Renner, Lead, Independent Director
Kathryn Froh, Vice President - Diagnostics
Martin Marino, Independent Chairman of the Board
Cameron Groome, President, Chief Executive Officer, Director
James Currie, Chief Financial Officer
Vaughn EmbroPantalony, President CEO, Director
Kenneth Hughes, Chief Operating Officer
Peter Blecher, Independent Director

Microbix Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Microbix Biosystems a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Microbix Biosystems

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Microbix Biosystems position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Microbix Biosystems will appreciate offsetting losses from the drop in the long position's value.

Moving against Microbix Stock

  0.88WMT Walmart Inc CDRPairCorr
  0.84AMZN Amazon CDRPairCorr
  0.8NVDA NVIDIA CDRPairCorr
  0.76TSLA Tesla Inc CDRPairCorr
  0.72GOOG Alphabet CDRPairCorr
The ability to find closely correlated positions to Microbix Biosystems could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Microbix Biosystems when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Microbix Biosystems - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Microbix Biosystems to buy it.
The correlation of Microbix Biosystems is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Microbix Biosystems moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Microbix Biosystems moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Microbix Biosystems can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in Microbix Stock

Microbix Biosystems financial ratios help investors to determine whether Microbix Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Microbix with respect to the benefits of owning Microbix Biosystems security.